Speciallægen på Søndervangen 47 ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 0.0% 1.2% 1.2%  
Credit score (0-100)  0 0 0 82 80  
Credit rating  N/A N/A N/A A A  
Credit limit (kDKK)  0.0 0.0 0.0 297.2 253.9  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 3,328 3,874  
EBITDA  0.0 0.0 0.0 1,191 1,460  
EBIT  0.0 0.0 0.0 196 443  
Pre-tax profit (PTP)  0.0 0.0 0.0 180.1 433.7  
Net earnings  0.0 0.0 0.0 140.2 336.0  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 180 434  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 2,234 1,760  
Shareholders equity total  0.0 0.0 0.0 8,784 9,002  
Interest-bearing liabilities  0.0 0.0 0.0 14.4 5.4  
Balance sheet total (assets)  0.0 0.0 0.0 10,139 10,354  

Net Debt  0.0 0.0 0.0 -4,831 -6,034  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 3,328 3,874  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 16.4%  
Employees  0 0 0 0 4  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 10,139 10,354  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% 2.1%  
Added value  0.0 0.0 0.0 195.5 1,459.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 3,859 -1,927  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 1.0 2.0  

Profitability 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% 5.9% 11.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% 1.9% 4.3%  
ROI %  0.0% 0.0% 0.0% 2.0% 4.5%  
ROE %  0.0% 0.0% 0.0% 1.6% 3.8%  

Solidity 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 0.0% 0.0% 86.6% 86.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% -405.7% -413.4%  
Gearing %  0.0% 0.0% 0.0% 0.2% 0.1%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 214.4% 94.2%  

Liquidity 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 0.0 12.5 10.8  
Current Ratio  0.0 0.0 0.0 12.5 10.8  
Cash and cash equivalent  0.0 0.0 0.0 4,845.8 6,039.7  

Capital use efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 4,733.9 5,689.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 365  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 365  
EBIT / employee  0 0 0 0 111  
Net earnings / employee  0 0 0 0 84